Workflow
生物技术药物
icon
Search documents
华北制药与关联财务公司签约,预计2025年发生金融业务20亿元
Xin Lang Cai Jing· 2025-05-23 13:16
Core Viewpoint - Huabei Pharmaceutical (600812.SH) has recently announced a series of agreements with its affiliated company regarding financial services, which has attracted investor attention [1]. Financial Services Agreement - Huabei Pharmaceutical plans to sign a financial services agreement with Jizhong Energy Group Financial Co., Ltd. to enhance capital efficiency, secure better deposit and loan rates, and reduce financing costs. The agreement will be valid for three years [2]. - The company expects to engage in various financial transactions totaling 2 billion yuan in 2025, including deposit and loan services [2][3]. Financial Company Overview - Jizhong Energy Group Financial Co., Ltd. has total assets of 20.63 billion yuan and liabilities of 14.64 billion yuan as of March 31, 2025. The company reported a net profit of 64.27 million yuan for the first quarter of 2025 [4][6]. - The financial company is controlled by the Hebei Provincial State-owned Assets Supervision and Administration Commission and provides services such as accepting deposits and granting loans [3][4]. Risk Management Measures - To ensure the safety of funds deposited with the financial company, Huabei Pharmaceutical has established a risk management plan, including a leadership group responsible for monitoring and managing risks [7]. - The company has also conducted a risk assessment report detailing the shareholding structure of the financial company, with Huabei Pharmaceutical holding a 20% stake [7]. Financial Performance - In the first quarter of 2025, Huabei Pharmaceutical achieved a revenue of 2.57 billion yuan, a year-on-year increase of 0.65%, and a net profit of 57.49 million yuan, up 216.72% compared to the previous year [10][11]. - The company's total assets increased by 2.43% year-on-year, reaching approximately 21.99 billion yuan [11]. Upcoming Shareholder Meeting - Huabei Pharmaceutical will hold its 2024 annual shareholder meeting on June 11, 2025, to discuss various proposals, including the 2024 Board of Directors' work report [10].